It was reported that there was an issue with the shunt system.The patient was initially implanted with a gav valve.Postoperatively, there was an unspecified dysfunction.Due to the malfunction, the valve was explanted on (b)(6) 2019.Additional information was not provided.
|
Manufacturing evaluation: the valve was received dry (not submersed in liquid as suggested).Visual inspection - no significant deformations or damage of the valve were detected during the visual inspection.Permeability test - results have shown that the valve has a blockage.Adjustment test - this is a fixed pressure valve.An adjustment test is n/a.Braking force and function test - this test is n/a.Results - it should be noted that the valve was received dry (i.E.Not submersed in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we have investigated the valve to the best of our abilities.After the tests, we have dismantled the valve.Inside the valve we found a build-up of substances (likely protein).Based on our investigation, we detect a presence of occlusion in the valve, likely due to the deposits observed inside the valve.As described in our literature, the problem encountered is one of the known, inevitable risks of hydrocephalus (hc) therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released.
|